Cue Health Says Its Voluntarily & Temporarily Pausing Sales & Distribution Of Currently Marketed EUA Covid-19 Test Cartridge; Actively Working With FDA To Quickly Resolve Issues That Were Raised And Is Working With Customers To Reach Appropriate Resolutions
Portfolio Pulse from Benzinga Newsdesk
Cue Health has announced a voluntary and temporary pause in the sales and distribution of its EUA Covid-19 test cartridge. The company is actively working with the FDA to resolve the issues raised and is collaborating with customers to find appropriate resolutions.
May 16, 2024 | 8:26 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cue Health has temporarily paused the sales and distribution of its EUA Covid-19 test cartridge due to issues raised by the FDA. The company is working to resolve these issues quickly and is in communication with its customers.
The temporary pause in sales and distribution of a key product due to regulatory issues is likely to negatively impact Cue Health's stock in the short term. The company's proactive approach to resolving the issues may mitigate some of the negative impact, but uncertainty remains until the issues are fully resolved.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100